Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 26th:
Caleres, Inc. (CAL - Free Report) : This footwear retailer, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.4% over the last 60 days.
Caleres has a PEG ratio 1.07, compared with 1.18 for the industry. The company possesses a Growth Score of A.
Hasbro, Inc. (HAS - Free Report) : This play and entertainment company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
Hasbro has a PEG ratio 1.83, compared with 2.17 for the industry. The company possesses a Growth Score of A.
Chemours Company (CC - Free Report) : This chemical company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.5% over the last 60 days.
Chemours has a PEG ratio 0.85, compared with 1.74 for the industry. The company possesses a Growth Score of A.
Cigna Corporation (CI - Free Report) : This health services company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
Cigna has a PEG ratio 1.35, compared with 1.52 for the industry. The company possesses a Growth Score of A.
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Trades Could Profit "Big-League" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 26th:
Caleres, Inc. (CAL - Free Report) : This footwear retailer, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.4% over the last 60 days.
Caleres has a PEG ratio 1.07, compared with 1.18 for the industry. The company possesses a Growth Score of A.
Hasbro, Inc. (HAS - Free Report) : This play and entertainment company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
Hasbro has a PEG ratio 1.83, compared with 2.17 for the industry. The company possesses a Growth Score of A.
Chemours Company (CC - Free Report) : This chemical company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.5% over the last 60 days.
Chemours has a PEG ratio 0.85, compared with 1.74 for the industry. The company possesses a Growth Score of A.
Cigna Corporation (CI - Free Report) : This health services company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.
Cigna has a PEG ratio 1.35, compared with 1.52 for the industry. The company possesses a Growth Score of A.
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Trades Could Profit "Big-League" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on HAS - FREE
Get the latest research report on CI - FREE
Get the latest research report on CAL - FREE
Get the latest research report on CC - FREE